Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Aerie Pharmaceuticals (AERI) News Today

Aerie Pharmaceuticals logo
20 Countries With Worst Vision Problems
Aerie Promo Codes
Angina Pectoris Drugs Global Market Report 2023
Ocular Hypertension Treatment Global Market Report 2023
I-Mab Announces the Appointment of Raj Kannan as CEO
I-Mab Names Raj Kannan CEO - Quick Facts
Ophthalmic Drugs Global Market Report 2023
ROCK2 Inhibitor Market 2023-2028: Future Updates
Rho Associated Protein Kinase 2 Market by 2031
Get Aerie Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for AERI and its competitors with MarketBeat's FREE daily newsletter.

We recommended Palantir in 2021, now we’re recommending this... (Ad)

My research indicates there is only one investment that can meet AI's unprecedented demand for energy.

Click to get the name and ticker symbol

AERI Media Mentions By Week

AERI Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AERI
News Sentiment

0.00

0.60

Average
Medical
News Sentiment

AERI News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AERI Articles
This Week

0

0

AERI Articles
Average Week

Get Aerie Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for AERI and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:AERI) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners